Close

Canaccord Genuity Reiterates a 'Buy' on Anacor Pharmaceuticals (ANAC); Tavaborole Phase 3 Design Supports Success, Approval

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/25/2024

1. META
2. CMG
3. IBM
4. HCP
5. PI
6. BSX
7. LRCX
8. BA
9. BIIB
10. F


Go back to Canaccord Genuity Reiterates a 'Buy' on Anacor Pharmaceuticals (ANAC); Tavaborole Phase 3 Design Supports Success, Approval
ANACOR PHARM (NYSE: ANAC) Delayed: 10.19 --0 (-0%)
Previous Close $10.19    52 Week High $156.93 
Open $10.19    52 Week Low $52.00 
Day High $10.19    P/E N/A 
Day Low $10.19    EPS $-1.54 
Volume 2